A Tarkowski Selected Research

Arthritis (Polyarthritis)

03/2008	The impact of substance P signalling on the development of experimental staphylococcal sepsis and arthritis.
01/2005	Extracellular cytochrome c, a mitochondrial apoptosis-related protein, induces arthritis.
12/2002	Interleukin-10 ameliorates the outcome of Staphylococcus aureus arthritis by promoting bacterial clearance.
09/2002	Total abrogation of collagen II-induced arthritis and the B cell response to type II collagen using suboptimal doses of a topoisomerase II antagonist.
09/2002	Intra-articular tissue factor/factor VII complex induces chronic arthritis.
06/2001	Impact of transcription factors AP-1 and NF-kappaB on the outcome of experimental Staphylococcus aureus arthritis and sepsis.
01/2001	Synovial cytokine mRNA expression during arthritis triggered by CpG motifs of bacterial DNA.
01/2001	Role of IL-12 in Staphylococcus aureus-triggered arthritis and sepsis.
10/2000	The major role of macrophages and their product tumor necrosis factor alpha in the induction of arthritis triggered by bacterial DNA containing CpG motifs.
06/2000	Role of selectins in experimental Staphylococcus aureus-induced arthritis.
02/2000	The features of arthritis induced by CpG motifs in bacterial DNA.

11	Arthritis (Polyarthritis) 03/2008 - 02/2000
5	Rheumatoid Arthritis 10/2007 - 10/2003
4	Sepsis (Septicemia) 03/2008 - 01/2001
2	Infection 05/2003 - 01/2001
2	Infectious Arthritis (Septic Arthritis) 01/2001 - 07/2000
1	Experimental Arthritis 02/2005
1	Inflammation 08/2003
1	Inclusion Body Myositis 07/2003
1	Central Nervous System Vasculitis 03/2002
1	Meningitis 10/2001
1	Alzheimer Disease (Alzheimer's Disease) 03/2001
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 03/2001
1	Hemophilia A (Haemophilia) 04/2000
1	Central Nervous System Lupus Vasculitis 03/2000
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2000

5	Bacterial DNAIBA 10/2001 - 02/2000
2	Type II DNA Topoisomerases (Topoisomerase II)IBA 02/2005 - 09/2002
2	LeptinIBA 10/2003 - 01/2001
1	Substance PIBA 03/2008
1	Methotrexate (Mexate)FDA LinkGeneric 10/2007
1	AutoantibodiesIBA 08/2007
1	Histamine (Histamine Dihydrochloride)IBA 06/2007
1	Rheumatoid FactorIBA 01/2007
1	Immunoglobulin M (IgM)IBA 01/2007
1	CitrullineIBA 01/2007
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2007
1	Cytochromes c (Cytochrome c)IBA 01/2005
1	infliximab (Remicade)FDA Link 08/2003
1	Thomsen-Friedenreich antibodiesIBA 07/2003
1	gamma-delta T-Cell Antigen Receptors (T-Cell Receptor delta-Chain)IBA 05/2003
1	Interleukin-10 (Interleukin 10)IBA 12/2002
1	Factor VII (Proconvertin)IBA 09/2002
1	Collagen Type II (Type II Collagen)IBA 09/2002
1	Thromboplastin (Tissue Factor)IBA 09/2002
1	CollagenIBA 09/2002
1	Glial Fibrillary Acidic ProteinIBA 03/2002
1	NF-kappa B (NF-kB)IBA 06/2001
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 06/2001
1	Transcription Factors (Transcription Factor)IBA 06/2001
1	ThrombinIBA 04/2001
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2001
1	Interleukin-12 (IL 12)IBA 01/2001
1	Messenger RNA (mRNA)IBA 01/2001
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2000
1	SelectinsIBA 06/2000
1	Factor VIII (Coagulation Factor VIII)IBA 04/2000
1	CytokinesIBA 01/2000

1	Stem Cell Transplantation 03/2000